Articles related to LUNG CANCER

Explore the indicators of lung cancer, including persistent cough and unexplained weight loss, which may help in its early detection and improve patient outcomes.

In a recent phase 3 trial, alectinib has shown a notable improvement in both disease-free and CNS disease-free survival in patients with ALK-positive NSCLC, indicating a robust alternative to platinum-based chemotherapy regimens.

In a recent case, symptomatic joint pain and distinctive physical signs in a patient led to the identification of non-small-cell lung cancer, highlighting the critical role of thorough clinical assessment in revealing potential underlying malignancies.

Explore the latest advancement in NSCLC treatment: the FDA-approved amivantamab combo has demonstrated a significant leap in progression-free survival for patients with specific genetic mutations, reshaping the standard of care.

In a sobering case from the Omaha VA Medical Center, the failure to follow up on a lung nodule resulted in a veteran’s preventable late-stage lung cancer, highlighting the imperative for rigorous oversight in patient care tracking systems.

In an alarming case at the Omaha VA Medical Center, a year-long gap in monitoring the lung imaging registry led to serious patient care oversights, including a veteran’s undiagnosed lung cancer progression. This incident highlights the critical need for continuous and vigilant monitoring in healthcare systems.